Janssen Pharmaceutica fined $1.2 billion

April 12, 2012 at 2:03 AM
share with facebook
share with twitter

LITTLE ROCK, Ark., April 12 (UPI) -- Johnson & Johnson subsidiary Janssen Pharmaceutica was fined $1.2 billion by a county judge in Arkansas Wednesday for Medicaid fraud.

Pulaski County Circuit Judge Timothy Fox ordered Janssen Pharmaceutica to pay $5,000 per offense for 238,874 prescriptions paid by the state's Medicaid program, a total of $1,194,370,000, Little Rock's KARK-TV reported.

The judge's financial penalty came the day after a jury found the company had engaged in fraud and deceptive trade practices by not disclosing or minimizing possibly dangerous side effects of its anti-psychotic medication Risperdal.

The TV station said the company is expected to file an appeal in the lawsuit, which was filed in 2007.

"This is a big win for Arkansas," state Attorney General Dustin McDaniel said in a statement. "Today's imposition of more than $1.2 billion in penalties sends a clear signal that big drug companies like Johnson & Johnson and Janssen Pharmaceuticals cannot lie to the FDA [Food and Drug Administration], patients and doctors in order to defraud Arkansas taxpayers of our Medicaid dollars. These two companies put profits before people, and they are rightfully being held responsible for their actions."

Related UPI Stories
Trending Stories